The life science industry faces major challenges across the board, including a slump in M&A, lack of funding, patent expiration, growing compliance demands, and a tight labor market.
While dealing with these headaches, biotech managers may be tempted to skimp on securing and keeping top environmental, health, and safety (EHS) talent. But this is a mistake—potentially a fatal one for organizations looking to safely and efficiently innovate, go to market, or maintain competitiveness.